pneumonia
Risks and challenges of the agent of the lung disease Mycoplasma pneumoniae
The prevalence of this atypical lung infection agent is widely underestimated - people are often not even aware that they have it - and many antibiotics cannot effectively treat it; Mycoplasma pneumoniae outbreaks occur every few years. This winter, countries like China, Denmark, France and the Netherlands reported an increase in cases, especially in children. ...
Tocilizumab : a treatment alternative in COVID-19 pneumonia
Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.
A scientist’s opinion : Interview with Prof Cristina Mussini about covid-19 treatment
Interview with Professor Cristina Mussini, Head of the Department of Infectious Diseases and Tropical Medicine at the University of Modena and Reggio Emilia in Italy and member of the European AIDS Clinical Society. She has been actively involved in various recent studies on the clinical use of tocilizumab in patients with COVID-19 pneumonia. First a ...
A scientist’s opinion : Interview with Dr Andrew Ip about covid-19 treatment
Interview with Dr Andrew Ip, a specialist in hematology/oncology at the John Theurer Cancer Center at Hackensack University Medical Center, USA, who has been involved in research on tocilizumab use in COVID-19 patients. Why did you choose tocilizumab to treat patients with COVID-19 pneumonia? Andrew Ip: Tocilizumab is a monoclonal antibody that inhibits the interleukin-6 ...
A scientist’s opinion : Interview with Dr Juan Victor San-Martin Lopez about covid-19 treatment
Interview with Dr Juan Victor San-Martín López, a physician specialising in infectious diseases and a member of the task force coordinating responses to the leishmaniasis outbreak in 2011 and to COVID-19 at the Hospital Universitario de Fuenlabrada, Spain. He reports on his experience with tocilizumab use in COVID-19 patients. What is the so-called cytokine storm? ...
